U.S. Food Stock News

FuboTV Q2 2026 earnings snapshot FuboTV (FUBO) has posted its Q2 2026 numbers with revenue of US$1.6b, a basic EPS loss of US$0.07 and net income loss of US$2.1m, setting the stage for fresh scrutiny of the stock at a share price of US$10.43. The company has seen quarterly revenue move from US$1.1b in Q2 2025 to US$1.6b in Q2 2026. Quarterly EPS shifted from a loss position reflected in the trailing twelve month EPS of US$2.88 to the latest quarterly loss of US$0.07, giving investors a...

Douglas Emmett (DEI) opened Q1 2026 with total revenue of US$251.0 million and basic EPS of a US$0.01 loss, while trailing 12 month figures show total revenue of US$1.0 billion and basic EPS of a US$0.16 loss. Over recent quarters the company has seen quarterly revenue move in a tight band around US$245.8 million to US$252.4 million, while basic EPS has ranged from a US$0.24 profit in Q1 2025 to losses of US$0.01 to US$0.07 per share in subsequent periods, providing a mixed backdrop for...

PennyMac Financial Services (PFSI) sets the tone with Q1 2026 earnings PennyMac Financial Services (PFSI) opened Q1 2026 with total revenue of US$545 million and basic EPS of US$1.58, setting a clear benchmark for how its earnings story is unfolding this year. The company reported quarterly revenue of US$862 million in Q1 2025 and US$883 million in Q4 2025, followed by US$545 million this quarter. Over the same period, basic EPS was US$1.48, then US$2.05, and now stands at US$1.58. With...

S&P Global Ratings upgraded Las Vegas Sands (NYSE:LVS) and its Macau unit to BBB from BBB-. The upgrade follows what S&P described as a disciplined financial policy, limited new development plans, and a recovery in Macau operations. Soon after the upgrade, Las Vegas Sands issued US$1b in new senior notes intended to refinance existing debt on improved terms. S&P also pointed to the potential for higher shareholder rewards, including the possibility of further share buybacks. For you as an...

Crexendo (CXDO) opened 2026 with Q1 total revenue of US$20.7 million and basic EPS of US$0.018, alongside trailing twelve month EPS of US$0.147 on revenue of US$72.8 million, giving investors a fresh read on both quarterly momentum and the broader run rate. Over recent periods, the company has seen quarterly revenue move from US$16.1 million in Q1 2025 to US$20.7 million in Q1 2026, while basic EPS shifted from US$0.0418 to US$0.018 on a quarterly basis and from US$0.0888 to US$0.147 on a...

SelectQuote (SLQT) just reported a busy Q2 2026, with total revenue of US$537.1 million and net income of US$51.2 million, which translated to basic EPS of US$0.27. The company’s quarterly revenue had previously stood at US$481.1 million with EPS of US$0.31 in Q2 2025, followed by a mix of losses and profits in subsequent periods, before arriving at the current quarter’s figures. For you as an investor, this latest report highlights a balance between improving profitability on one hand and...

Voya Financial (VOYA) has wrapped up FY 2025 with fourth quarter revenue of US$2.1b and basic EPS of US$1.43, while net income excluding extra items came in at US$136m. The company has seen quarterly revenue move from US$2.0b and EPS of US$0.97 in Q4 2024 to US$2.1b and EPS of US$1.43 in Q4 2025. The trailing twelve months show revenue of US$8.2b, net income of US$613m and basic EPS of US$6.40, setting the backdrop for how investors judge the resilience of margins in this latest print. See...

Huron Consulting Group (HURN) opened 2026 with Q1 revenue of US$451.8 million and basic EPS of US$1.37, set against trailing twelve month revenue of about US$1.7 billion and EPS of US$6.02 as investors weigh how the latest quarter fits into the broader earnings trend. The company has seen quarterly revenue move from US$395.7 million in Q1 2025 to US$451.8 million in Q1 2026, while quarterly EPS tracked from US$1.38 to US$1.37 over the same period, leaving the headline numbers solid and...

Insulet (NasdaqGS:PODD) has begun its pivotal EVOLVE study of a fully closed loop automated insulin delivery system for people with type 2 diabetes. The first participant has been enrolled, marking an important step in testing this technology beyond the company’s existing Omnipod 5 offering. The study focuses on expanding automated insulin delivery to a large and currently underserved segment of the diabetes population. For investors watching Insulet at a share price of $151.28, the EVOLVE...

If you are wondering whether Willis Lease Finance at around US$229 per share still offers value, you are not alone in asking what the current price really reflects. The stock has recently posted returns of 19.6% over 7 days, 30.2% over 30 days, 70.8% year to date and 72.3% over 1 year, with very large gains over 3 and 5 years. Recent headlines have focused on Willis Lease Finance within the capital goods and aircraft leasing space, highlighting how investors are paying closer attention to...

Q1 earnings, tax effects and new partnership shape investor focus Preformed Line Products (PLPC) drew attention after Q1 2026 results showed higher net sales but lower net income, along with a broker downgrade, a new FulcrumAir partnership, and a quarterly dividend announcement. See our latest analysis for Preformed Line Products. The stock has reacted strongly to the Q1 update, the FulcrumAir partnership and the dividend news, with a 1 month share price return of 25.33% and a year to date...

Edgewise Therapeutics recently reported positive outcomes from drug trials and FDA-related developments, while also granting inducement stock options for 266,000 shares to nine new non-executive employees under its 2024 Inducement Equity Incentive Plan. These clinical updates, combined with a catalyst-rich pipeline and management’s decision to expand the team with equity-linked hires, highlight the company’s focus on executing its late- and mid-stage programs. We’ll now examine how the...

Talen Energy (TLN) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$1.38, alongside trailing 12 month revenue of US$3.4 billion and a small net loss of US$21 million that translates to basic EPS of US$0.46 in the red. Over recent quarters, the company has seen revenue range from US$454 million to US$1.1 billion and basic EPS swing between a loss of US$7.95 and a gain of US$4.53. This sets up a results season where investors will be focused on how consistently those higher...

Entravision Communications (EVC) has opened 2026 with Q1 revenue of US$197.0 million and basic EPS of US$0.13, alongside net income from ongoing operations of US$12.4 million. The company has seen revenue move from US$91.9 million in Q1 2025 and US$107.0 million in Q4 2024 to US$197.0 million in Q1 2026. EPS has shifted from losses of US$0.53 and US$0.62 in those respective quarters to a profit in the latest period, setting up a quarter where investors will be focused on how durable these...

BigBear.ai Holdings (BBAI) opened Q1 2026 with revenue of about US$34.4 million and a basic EPS loss of roughly US$0.12, setting the tone for another quarter where growth and profitability are pulling in different directions. Over recent periods, revenue has moved between US$27.3 million and US$43.8 million a quarter, while basic EPS has ranged from a small profit of about US$0.01 to a loss of roughly US$0.71, underscoring how volatile margins have been as the business scales. In that...

Angi (ANGI) posts FY 2025 results with steady profitability and modest top line Angi (ANGI) closed FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.17, while trailing twelve month EPS reached US$0.96 on net income of US$43.8 million, setting a clear reference point for the year at a share price of US$7.41. Over the past six reported quarters, revenue has ranged from US$240.8 million to US$296.7 million, while quarterly basic EPS has moved between a loss of US$0.03...

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...

Hecla Mining (HL) earnings snapshot Hecla Mining (HL) has put fresh numbers on the table for Q1 2026, with revenue of US$411.4 million, basic EPS of US$0.25 and net income from continuing operations of US$164.5 million, while also reporting earnings from discontinued operations of US$183.7 million. Over the past year, the company has seen revenue move from US$929.9 million on a trailing basis to US$1.57 billion and EPS shift from US$0.06 to US$0.69, alongside a very large year over year...

Lucid Group (LCID) has just wrapped up FY 2025 with fourth quarter revenue of US$522.7 million, a basic EPS loss of US$3.62, and net income loss of US$1.18 billion. The trailing twelve month figures show revenue of US$1.35 billion and a basic EPS loss of US$11.81. The company’s revenue has moved from US$807.8 million on a trailing basis at the end of 2024 to US$1.35 billion by the end of 2025. EPS has remained deeply negative over the same stretch, setting up a results season in which...

Assurant (AIZ) kicked off 2026 with Q1 revenue of US$3.4 billion and basic EPS of US$5.51, alongside net income excluding extra items of US$274.1 million, setting a clear marker for how the year is starting to shape up. Over recent quarters the company has seen revenue move from US$3.1 billion in Q1 2025 to US$3.4 billion in Q1 2026. Basic EPS has ranged between US$2.86 and US$5.23 in 2025 before reaching US$5.51 this quarter, giving you a clear view of how the income line has been tracking...

Jackson Financial's Q1 2026 Numbers Set the Stage for a Margin Story Jackson Financial (JXN) has opened 2026 with Q1 revenue of about US$2.9 billion and a basic EPS loss of US$6.24, alongside a trailing twelve month EPS loss of US$5.94 and net income loss of US$417 million. The company has seen quarterly revenue range from US$245 million in Q4 2024 to US$3.8 billion in Q1 2025. Basic EPS has swung between a profit of US$4.50 in Q4 2024 and the current Q1 2026 loss, which puts investor...

Azenta (AZTA) has put a tough quarter on the table, with Q2 2026 revenue of US$144.8 million and a basic EPS loss of US$3.41, alongside net income from continuing operations showing a loss of US$157.0 million. The company has seen quarterly revenue move from US$143.4 million in Q2 2025 to US$158.0 million in Q4 2025 and then to US$144.8 million in Q2 2026. EPS has swung from a loss of US$0.40 in Q2 2025 to a profit of US$1.12 in Q4 2025 and back to a loss of US$3.41 in the latest quarter,...

Rigel Pharmaceuticals (RIGL) opened 2026 with Q1 revenue of US$58.8 million and basic EPS of US$0.47, alongside trailing 12‑month revenue of US$299.8 million and basic EPS of US$20.08, set against very large year over year earnings growth and higher net profit margins in the latest trailing figures. Over recent quarters the company has seen revenue move from US$57.6 million in Q4 2024 to US$53.3 million in Q1 2025, US$101.7 million in Q2 2025, US$69.5 million in Q3 2025 and US$69.8 million in...

Q1 2026 earnings snapshot Duolingo (DUOL) opened 2026 with Q1 revenue of US$292.0 million and basic EPS of US$0.93, setting the tone for the latest results at a share price of US$105.02. Over the past year, the company has seen revenue move from US$230.7 million in Q1 2025 to US$292.0 million in Q1 2026, while basic EPS shifted from US$0.78 to US$0.93, against a trailing twelve month EPS figure of US$9.14. With trailing net profit margins now framed by a much higher earnings base, the story...